Catalio, Tressa C.

HRN: 28-38-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
CEFAZOLIN 1GM (VIAL)
02/03/2026
02/03/2026
IVTT
2g
Now
Cs
Remove - Pending Acceptance
02/03/2026
CEFAZOLIN 1GM (VIAL)
02/03/2026
02/04/2026
IV
1 Gram
Q8h
S/P CS
Remove - Pending Acceptance
02/03/2026
CEFUROXIME 500MG (TAB)
02/04/2026
02/11/2026
PO
1 Tab
BID
S/P CS
Remove - Pending Acceptance
02/03/2026
METRONIDAZOLE 500MG (TAB)
02/03/2026
02/05/2026
IV
500mg
Q8h
S/P CS
Remove - Pending Acceptance
02/03/2026
METRONIDAZOLE 500MG (TAB)
02/05/2026
02/12/2026
PO
1 Tab
BID
S/P
Remove - Pending Acceptance
02/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/04/2026
02/11/2026
IV
500
Q8
S/P LTCS
Remove - Pending Acceptance
02/05/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2026
02/12/2026
IV
900
Q8
Ltcs
Remove - Pending Acceptance
02/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2026
02/06/2026
IV
4.5g
Now
T/cTyphoid S/p CS
Remove - Pending Acceptance
02/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2026
02/11/2026
IV
2.5g
Q6
T/c Typhoid S/p Cs
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: